Overcoming Barriers to Biosimilar Adoption: Commentary on “Cost to Medicare of Delayed Adalimumab Biosimilar Availability”

Saved in:
Bibliographic Details
Published in:Clinical pharmacology and therapeutics 2022-07, Vol.112 (1), p.25-27
Main Authors: Arad, Nitzan, Kroetsch, Adam, McClellan, Mark
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0009-9236
1532-6535
DOI:10.1002/cpt.2403